Table 1: The demographic characteristic of the patients treated with brodalumab.
Patient |
Age |
Sex |
PsoA |
Duration of disease (years) |
Nails Involvement |
Palmo-plantar |
Genitalia |
Scalp |
Previous biologic treatments |
Comorbidities |
1 |
28 |
M |
no |
10 |
no |
Yes |
yes |
no |
none |
none |
2 |
61 |
M |
no |
30 |
no |
no |
no |
yes |
none |
hypercolesterolemia |
3 |
50 |
M |
No |
3 |
Yes |
Yes |
No |
no |
none |
none |
4 |
22 |
M |
No |
2 |
No |
No |
No |
no |
none |
None |
5 |
49 |
F |
No |
1 |
No |
No |
No |
yes |
none |
Obesity, T2DM, Hypertension |
6 |
66 |
M |
no |
15 |
no |
yes |
yes |
yes |
Ixekizumab |
none |